Sage Journals: Discover world-class research

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Sage Journals: Discover world-class research

Journal of Child and Adolescent Psychopharmacology

Impact Factor: 2.2

Journal Homepage Submission guidelines

Restricted access

News

First published online August, 2010

Volume 20, Issue 4

https://doi.org/10.1089/cap.2010.2042

Abstract

Get full access to this article

View all access options for this article.

References

1.

Thurstone

C

, Riggs

PD

, Salomonsen-Sautel

S

, Mikulich-Gilberston

SK

. Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry, 49:573–582. 2010.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

The Adequacy of Commitment Evaluations Performed by Psychiatric and Non-psychiatric Physicians

Retricted access

MADD Massachusetts Versus Senator Burke: A Media Advocacy Case Study

Retricted access

Retricted access

Diclofenac Increases Beta-Endorphin Plasma Concentrations